Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Controversial ALS drug from Amylyx gets rare second FDA meeting

Amylyx Pharmaceuticals Inc.’s controversial treatment for amyotrophic lateral sclerosis won the support of a panel of U.S. regulatory advisers, putting the product on track for likely clearance.

Tribune News Service

HRT medicine to be sold without prescription for the first time

It is the first time women will be able to buy a certain type of hormone replacement therapy from a high street chemist without a prescription.

The Independent UK

New malaria vaccine comes a step closer as experts say it’s ‘the best yet’

Chance to eradicate diseases such as malaria could be lost and UK innovation squandered if global health investment is cut, jab co-creator tells PM

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Intradermal Ketamine Patch Completes Pre-Clinical Phase, Advances To Clinical Studies

PharmaTher Holdings (OTCQB: PHRRF), the biopharma company developing novel uses and delivery forms of ketamine for mental health treatments, has completed an IND-enabling pharmacokinetic and tolerability study of its ketamine patch, KETARX, in minipigs.

Benzinga

Government admits 50 firms were in VIP lane for test and trace contracts

Health department had denied Covid testing priority lane but new disclosure lists firms including lab behind false negatives

The Guardian - UK

Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Pfizer’s (NYSE:PFE) lead drug GBS6 or PF-06760805 for the prevention of invasive GBS disease due to the vaccine serotypes in newborns and young infants by active immunization of their mothers during pregnancy. Pfizer shares traded in a…

Benzinga

No, COVID-19 isn’t winding down, scientists say, predicting it’ll be around the rest of our lives

Even with new boosters, experts predict the scourge that’s already lasted longer than the 1918 flu pandemic will linger far into the future. Here’s why.

Chicago Sun-Times

Read news from The Economist, FT, and more,
with one subscription

ALS drug gets rare second review at high-stakes FDA meeting

The Food and Drug Administration is holding an unusual second meeting to review a closely watched drug for the illness known as Lou Gehrig’s disease

The Independent UK

E-Cigarette Maker To Pay Over $430M To Settle Multi-State Vaping Inquiry, Cannabis Investors Need To Pay Attention

E-cigarette producer Juul Labs agreed to pay $438.5 million to 34 states and territories to sort out a two-year bipartisan investigation into its marketing and sales practices.

Benzinga

Mark Cuban Says 'Pharma Bro' Martin Shkreli Inspired His Cost Plus Drug Company

Billionaire investor and Dallas Mavericks owner Mark Cuban, who has revolutionized healthcare with his “Cost Plus Drug Company,” has taken inspiration from someone who is an antithesis of sorts, the Shark Tank investor revealed to Re

Benzinga

Tissue Regenix narrows losses but lingering impact of Covid weighs on healthcare market

The Leeds-based creator of regenerative medical devices increased revenues across the first half of 2022

Birmingham Post

Fear-mongering about fentanyl for kids

One expert characterized the DEA's claims as propaganda that was "divorced from reality"

Salon

Cathie Wood's Psychedelics Fund ARK Analyzes The Sector's Present & Future And Likes What It Sees

Cathie Wood’s ARK Genomic Revolution EFT has been making big investments in the psychedelics sector since February 2022, most notably in A

Benzinga

Talented cricketer was supplying 'laughing gas' to Nottingham students

Canisters of the drug were found in a car

Nottingham Post

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Illumina Stock Pops After European Regulators Block $8 Billion Deal

Illumina stock jumped Tuesday after the EC blocked its acquisition of Grail — another step in a battle over the early cancer-detection outfit.

Reuters

Argentina hikes biofuel prices for domestic market

Argentina's government on Tuesday increased domestic prices of biodiesel for blending with diesel, as well as for bioethanol made from sugarcane and corn.

Benzinga

Tetra Partners With Cellvera To Develop An Oral Treatment For COVID-19

Tetra Bio-Pharma Inc.

Daily Mirror

When will Omicron boosters be available? Who is eligible for Covid jab and how to book

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved a second Coronavirus booster vaccine to target the Omicron variant ahead of the autumn booster programme

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

What is rotavirus and why is it in the news?

Everything you need to know about rotavirus

The Guardian - US

The abortion rights movement can learn from the Aids activism of the 80s and 90s

Act Up employed a multiplicity of tactics and responses while maintaining a laser-focused singleness of purpose

Newsroom.co.nz

Application for Omicron vaccine expected in 'the coming months'

It could take several months for Pfizer's new Omicron-specific vaccines to be available in New Zealand.

Bangkok Post

CanSino's inhaled Covid-19 vaccine gets emergency use approval in China

HONG KONG: China's CanSino Biologics Inc said on Sunday that its recently developed Covid-19 vaccine has been approved by the country's drug regulator for emergency use as a booster, potentially benefiting its business.

Reuters

CanSino's inhaled COVID-19 vaccine gets emergency use approval in China

China's CanSino Biologics Inc said on Sunday that its recently developed COVID-19 vaccine has been approved by the country's drug regulator for emergency use as a booster, potentially benefiting its business.

Evening Standard

Second Covid booster jab approved in UK ahead of winter vaccine programme

It’s the second jab aimed at both the original and Omicron strains of the virus, to be approved in the UK

Daily Mirror

New 'second generation' Pfizer Covid vaccine approved ahead of booster programme

The "bivalent" jab - which targets Omicron as well as the original strain of the deadly virus - is manufactured by Pfizer/Biotech, and follows a similar booster from Moderna approved last month

1 … 129 130 131 132

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Amyotrophic lateral sclerosis

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.